1998
DOI: 10.1212/wnl.51.4.1216
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic role of Mantoux test site biopsy in neurosarcoidosis

Abstract: We discuss a patient with sarcoidosis presenting with cranial neuropathy and a cerebral mass lesion evident on imaging. Also, we review from the literature six patients with sarcoidosis presenting with cerebral mass lesion. We emphasize the diagnostic role of Mantoux test site biopsy in patients with dominant or isolated neurologic presentation because the involved sites are not easily accessible and Kveim's test antigen is not commercially available.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
3
0

Year Published

2001
2001
2020
2020

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 4 publications
1
3
0
Order By: Relevance
“…Other causes for this reaction at the Mantoux site could include a sarcoidal reaction at the injection site or a tuberculoid granuloma due to active tuberculosis. Typical sarcoidal granulomas have been reported at the Mantoux site in patients with sarcoidosis, and it has been proposed that this be used as a screening test for this disease 4 . The histopathology in our case clearly excludes this possibility, as there was a complete absence of sarcoidal or tuberculoid granulomas in the specimen.…”
Section: Discussionsupporting
confidence: 52%
See 1 more Smart Citation
“…Other causes for this reaction at the Mantoux site could include a sarcoidal reaction at the injection site or a tuberculoid granuloma due to active tuberculosis. Typical sarcoidal granulomas have been reported at the Mantoux site in patients with sarcoidosis, and it has been proposed that this be used as a screening test for this disease 4 . The histopathology in our case clearly excludes this possibility, as there was a complete absence of sarcoidal or tuberculoid granulomas in the specimen.…”
Section: Discussionsupporting
confidence: 52%
“…These changes peak 48–72 hours after the injection and usually subside over 2 weeks. Mantoux test reaction is not a foreign body type response 4 …”
Section: Discussionmentioning
confidence: 99%
“…4 Historically, the injection of antigen prepared from the liver or spleen of patients with sarcoidosis (the Kveim test) has been used for diagnosis but it is not well-standardized, nor commercially available. 6,14 More recently, the Mantoux test site biopsy has been proposed as an alternative. 14 A standard forearm skin Mantoux test is done and is typically negative, but skin biopsy of the site at a later date may reveal noncaseating granulomas.…”
Section: Discussionmentioning
confidence: 99%
“…[ 2 ] On the other hand, delayed development (usually after 4 to 6 weeks) of sarcoidal granulomas at TST sites has previously been reported in established pulmonary and neurosarcoidosis. [ 3 ] Although the exact prevalence of such a response varies (possibly depending on the site involved and severity), these delayed “reactions” are not reproducible with other skin antigens in control testing. [ 4 ] Whether this represents a specific immune response to the purified protein derivative or reflects the pathogenic role of mycobacterial antigens in the development of sarcoidosis remains unclear.…”
mentioning
confidence: 99%